[1] |
PU Shanyu, PAN Yuesong, WANG Yongjun.
Unsupervised Learning-Based Identification of Responders to Indobufen Treatment in Acute Moderate-to-Severe Ischemic Stroke
[J]. Chinese Journal of Stroke, 2025, 20(4): 410-417.
|
[2] |
ZHOU Hang, CHEN Gao.
Possibility of Early Use of Aspirin after Spontaneous Intracerebral Hemorrhage Surgery: The First High-Level Evidence-Based Evidence for Perioperative Management of Intracerebral Hemorrhage from Chinese Scholars
[J]. Chinese Journal of Stroke, 2025, 20(1): 26-28.
|
[3] |
GUO Shuaiwei, ZHANG Ya’nan, WANG Shuo.
The Status and Significance of Platelet
Function Tests in the Assessment of Hemostatic Function in Neurosurgery
[J]. Chinese Journal of Stroke, 2024, 19(7): 848-853.
|
[4] |
XIE Yaoyi, HUANG Yanju, FAN Min, CEN Huatao, LI Yanli, LU Miaozhi, LU Boan, WEI Rangfang, WU Zhiwu.
Study on the Clinical Efficacy of Antiplatelet Therapy Guided by CYP2C19 Gene Detection in Ischemic Stroke Patients of Different Ethnic Groups
[J]. Chinese Journal of Stroke, 2024, 19(10): 1119-1124.
|
[5] |
HOU Yuting, LI Tong.
A Case Report of Dual Antiplatelet Therapy for Acute Basilar Artery Occlusion Based on Rapid CYP2C19 Gene Detection
[J]. Chinese Journal of Stroke, 2024, 19(10): 1125-1130.
|
[6] |
FANG Xiaomeng, YUAN Qiaoling, WANG Shuo.
Factors Related to the Deep Vein Thrombosis in Severe Spontaneous Intracerebral Hemorrhage Patients after Surgical Treatment
[J]. Chinese Journal of Stroke, 2023, 18(8): 891-897.
|
[7] |
.
Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition) (Excerpt)——Chapter Four Clinical Management of Ischaemic Cerebrovascular Diseases
[J]. Chinese Journal of Stroke, 2023, 18(8): 910-933.
|
[8] |
LI Zhenhua, ZHANG Jiangang, XIE Weizheng, WANG Yu, LUO Xue, LIU Conghui, SUN Ke, YANG Qingcheng, GUO Yanping.
Efficacy and Safety Study of Dual Antiplatelet Versus Alteplase in the Treatment of Acute Mild Non-Disabling Ischemic Stroke
[J]. Chinese Journal of Stroke, 2023, 18(12): 1391-1396.
|
[9] |
YU Wenlong, BAI Ruyu, YU Yanxue, GUO Xia, WU Lie.
Real World Study on the Current Status and Influencing Factors of Antiplatelet Aggregation Drugs Use among People Aged 40 and above in Baotou, Inner Mongolia
[J]. Chinese Journal of Stroke, 2023, 18(06): 651-659.
|
[10] |
LI Zhenhua, LIU Zhu, HU Quanzhong.
Progress in Drugs Therapy for Non-disabling Ischemic Cerebrovascular Events
[J]. Chinese Journal of Stroke, 2022, 17(04): 407-412.
|
[11] |
ZHANG Junliang, HUANG Shuangfeng, XU Luyao, XIANG Wei, ZHANG Manman, LIANG Zhigang.
Safety and Efficacy of Tirofiban in the Treatment of Mild to Moderate Non-Cardiogenic Ischemic Stroke Screened by MRI
[J]. Chinese Journal of Stroke, 2022, 17(01): 66-72.
|
[12] |
WANG Cong-Jie, LI Hong, ZHENG Li, LIU Shan, LU Hai-Li, CHEN Na, ZHANG Bin, ZHOU Heng.
Efficacy of Dual Antiplatelet Therapy after Intravenous Thrombolysis in Patients with Mild Ischemic Stroke
[J]. Chinese Journal of Stroke, 2021, 16(10): 1044-1049.
|
[13] |
YU Yi-Jiao, LIU Li, DU Juan, LI Wei, LIN Tian,LU Dong-Xu, CAI Yi-Ling.
Clinical Features and Prognosis of Capsule Warning Syndrome
[J]. Chinese Journal of Stroke, 2020, 15(12): 1317-1321.
|
[14] |
MA Gao-Ting, MIAO Zhong-Rong.
Antiplatelet Therapy in Endovascular Treatment for Ischemic Cerebrovascular Disease
[J]. Chinese Journal of Stroke, 2020, 15(02): 202-208.
|
[15] |
Wang Yi-Long.
Strategy Selection of Antiplatelet Therapy for Ischemic Stroke in terms of the Ethnic Differences between Easterners and Westerners
[J]. Chinese Journal of Stroke, 2018, 13(05): 494-499.
|